REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 29 filers reported holding REDHILL BIOPHARMA LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $21,000 | -77.4% | 3,200 | -84.4% | 0.00% | -80.0% |
| Q1 2020 | $93,000 | -40.4% | 20,500 | +12.3% | 0.01% | +25.0% |
| Q2 2018 | $156,000 | +57.6% | 18,250 | -8.8% | 0.00% | +33.3% |
| Q1 2018 | $99,000 | -2.9% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $102,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 715,293 | $3,276,000 | 0.69% |
| GAGNON SECURITIES LLC | 392,245 | $1,796,000 | 0.27% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,976,476 | $9,052,000 | 0.18% |
| Annandale Capital, LLC | 43,532 | $199,000 | 0.12% |
| Henry James International Management Inc. | 75,078 | $344,000 | 0.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 38,581 | $177,000 | 0.09% |
| Claret Asset Management Corp | 62,730 | $287,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 104,754 | $480,000 | 0.05% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 17,089 | $78,000 | 0.05% |
| ARS Investment Partners, LLC | 52,495 | $240,000 | 0.02% |